-
Mashup Score: 0Registration | MDS 2023 | Myelodysplastic Syndromes - 1 year(s) ago
Registration for MDS 2023, the International Congress on Myelodysplastic Syndromes, taking place in Marseille, France, 3-6 May 2023
Source: MDS 2023Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration | MDS 2023 | Myelodysplastic Syndromes - 1 year(s) ago
Registration for MDS 2023, the International Congress on Myelodysplastic Syndromes, taking place in Marseille, France, 3-6 May 2023
Source: MDS 2023Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Only three weeks to go until #MDS23! Full coverage will be available @VJHemOnc with live updates from the meeting, so be sure to follow us so you don’t miss out! Register here: 👉https://t.co/TvlYZAE3J8👈 @MDSFoundation #MDS #MDS23 #MyelodysplasticSyndromes #HemOnc https://t.co/mzelPWCO8w
-
-
Mashup Score: 0Registration | MDS 2023 | Myelodysplastic Syndromes - 1 year(s) ago
Registration for MDS 2023, the International Congress on Myelodysplastic Syndromes, taking place in Marseille, France, 3-6 May 2023
Source: MDS 2023Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're pleased to be a media partner for the upcoming #MDS23 congress that will be held in Marseille on 3-6 May, 2023 Register here: 👉https://t.co/DlWqFBGBHV 👈 @MDSFoundation #MyelodysplasticSyndromes #HemOnc #MDSsm https://t.co/U8srLSLZPr
-
-
Mashup Score: 1Vitamin B5 May Help Improve Red Blood Cell Production in Patients With Myelodysplastic Syndromes - The ASCO Post - 1 year(s) ago
By The ASCO Post Staff Posted: 3/2/2023 12:19:00 PM Last Updated: 3/2/2023 1:18:46 PM Researchers have discovered that vitamin B5 in combination with existing drugs may be the key to improving outcomes in patients with myelodysplastic syndrome (MDS) and ineffective red blood cell production, according to a…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Vitamin B5 May Help Improve Red Blood Cell Production in Patients With Myelodysplastic Syndromes https://t.co/GvWuNXkqXg #hematology #MDS #myelodysplasticsyndromes
-
-
Mashup Score: 0Novel agents in MDS - 1 year(s) ago
VJHemOnc is pleased to bring you a feature exploring the latest advances and developments in novel agents for MDS, with leading experts from ASH 2022.
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💡 Read about the latest advances in treatments for low and high-risk #MyelodysplasticSyndromes, including luspatercept, imetelstat, magrolimab, sabatolimab & CAR-T therapy! ➡️https://t.co/jhx7MDi0pk⬅️ #HemOnc #MDSsm #ImmunoOnc
-
-
Mashup Score: 0Novel agents in MDS - 1 year(s) ago
VJHemOnc is pleased to bring you a feature exploring the latest advances and developments in novel agents for MDS, with leading experts from ASH 2022.
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨Be sure to check our latest feature on novel agents in #MyelodysplasticSyndromes 👉 luspatercept 👉 imetelstat 👉magrolimab 👉sabatolimab 👉CAR-T ➡️https://t.co/mnJuWKRlic⬅️ #HemOnc #MDSsm #ImmunoOnc #tcellrx #CART
-
-
Mashup Score: 0Associations of Mutations in Spliceosome Genes With Ring Sideroblasts Verified in Myelodysplastic Syndromes - 1 year(s) ago
Researchers sought to verify the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in MDS.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers have confirmed the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in #myelodysplasticSyndromes. From @HematologyAdv. https://t.co/CPakB7ae1x #MDS
-
-
Mashup Score: 6Myelodysplastic Syndromes - 2 year(s) ago
This review summarizes current evidence regarding the epidemiology, clinical presentation, diagnosis, treatment, and prognosis of myelodysplastic syndromes.
Source: jamanetwork.comCategories: General Medicine News, Latest HeadlinesTweet-
New optimism on #myelodysplasticsyndromes @NEJMEvidence @JAMA_current @nejm https://t.co/Y9xsMlDZFT https://t.co/7RBfzxKs2X
-
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A recent #study has shown a crucial need to improve frontline therapy strategies for treating #myelodysplasticsyndromes. #Scientists are proposing a strategy for early intervention to enhance treatment outcomes for patients diagnosed with #MDS: https://t.co/jegqYZxloB https://t.co/E5E3AZXOpH
-
-
Mashup Score: 05-Year Follow-Up Suggests Luspatercept Safely Reduces Anemia in Patients With Lower-Risk Myelodysplastic Syndromes - 2 year(s) ago
A significant portion of patients with lower-risk myelodysplastic syndromes achieved red-blood transfusion independence with luspatercept with no new safety signals.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
5-Year Follow-Up Suggests Luspatercept Safely Reduces Anemia in Patients With Lower-Risk Myelodysplastic Syndromes #anemia #oncology #nursing #supportivecare #oncologynursing #MyelodysplasticSyndromes https://t.co/OceElMdV81
-
We're looking forward to the #MDS23 Congress that will be held in Marseille, France, on May 3-6, and we're pleased to be a media partner for this year's meeting. ➡️ Register for the meeting here: https://t.co/aVYveT4nP5 @MDSFoundation #MDS #MyelodysplasticSyndromes #HemOnc https://t.co/qxPyqwYZEy